Skip to content

Study · Measured the body's own peptide · 2003

1 result

Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.

Höybye C, Barkeling B, Espelund U, Petersson M, Thorén M

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society1 Dec 2003Cited by 53 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In adults with Prader-Willi syndrome, baseline plasma levels of the body's own oxytocin were within the normal range.

    In plain wordsIn adults with Prader-Willi syndrome, the body's own oxytocin level at the start was within the normal range.

    Peptide
    Oxytocin
    Outcome
    Not applicableBaseline plasma oxytocin
    Study

    n = 17

    Outcome group
    Endogenous peptide levels · Endocrine and hormones

    Measurements

    Plasma oxytocin
    14.7 pmol/L
    baseline, adults with Prader-Willi syndrome

    Source sentences

    Summary
    At baseline plasma mean oxytocin was within and serum ghrelin just above the normal range (14.7+/-1.2 pmol/L and 0.87+/-0.12 microg/L, respectively).
    1 context sentence
    Summary · context
    Seventeen adults, 9 men and 8 women, 17-32 years of age with a mean BMI of 35+/-3.2 kg/m(2) participated.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.